Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukoplakia, Oral × Metformin × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 3 Breast Neoplasms 2 Urothelial Cancer 1 TP53 Y220C Mutation 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Posterior Fossa Ependymal Tumor 1 Mouth Neoplasms 1 Leukoplakia, Oral 1 Hyperplasia 1 Erythroplasia 1 Advanced Solid Malignancies 1

Interventions

Photosensitizing Agents 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02581137 2026-03-18

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

National Cancer Institute (NCI)

Phase 2 Active not recruiting

26 enrolled 10 charts

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡